Sommaire

Numéro précédent | Numéro suivant

• • ·Consumer choices in Parkinson’s disease

    Page :525

     
• • ·Effects of fingolimod in relapsing-remitting multiple sclerosis

    Page :526-527

    Per Soelberg Sorensen

    
• • ·Occupational therapy for Parkinson’s disease: increasing awareness

    Page :527-529

    Marie Saint-Hilaire

    
• • ·Endovascular treatment for stroke: when does the window for good outcome close?

    Page :529-531

    Gregory W Albers

    
• • ·Paralysis lost: a new cause for a common parasomnia?

    Page :531-532

    David Rye

    
• • ·A population perspective on the IWG-2 research diagnostic criteria for Alzheimer’s disease

    Page :532-534

    Carol Brayne

    
• • ·Neuropathological processes in sepsis

    Page :534-536

    Tarek Sharshar, Fernando Bozza, Fabrice Chrétien

    
• • ·Corrections

    Page :536

    
• • ·Corrections

    Page :536

    
• • ·Corrections

    Page :536

    
• • ·Unruptured intracranial aneurysms: why we must not perpetuate the impasse for another 25 years

    Page :537-538

    Olivier Naggara, Tim Darsaut, Denis Trystram, Lambros Tselikas, Jean Raymond

     
• • ·Unruptured intracranial aneurysms: why we must not perpetuate the impasse for another 25 years – Authors’ reply

    Page :538

    Jacoba P Greving, Marieke J H Wermer, Gabriël J E Rinkel, Ale Algra

    
• • ·Developing biomarkers for cerebral amyloid angiopathy trials: do potential disease phenotypes hold promise?

    Page :538-540

    Andreas Charidimou, Hans Rolf J Jäger

     
• • ·Developing biomarkers for cerebral amyloid angiopathy trials: do potential disease phenotypes hold promise? – Authors’ reply

    Page :540

    Steven M Greenberg, Rustam Al-Shahi Salman, Geert Jan Biessels, Mark van Buchem, Charlotte Cordonnier, Jin-Moo Lee, Joan Montaner, Julie A Schneider, Eric E Smith, Meike Vernooij, David J Werring

    
• • ·Bruno Dubois: transforming the diagnosis of Alzheimer’s disease

    Page :541

    David Holmes

     
• • ·Michael Thomas Heneka

    Page :542

     
• • ·Defining narcolepsy

    Page :542

    Steven Goodrick

    
• • ·Addictive personalities

    Page :543

    Peter Ranscombe

     
• • ·News in brief

    Page :544

    Plan Plan  
• • ·Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial

    Page :545-556

    Peter A Calabresi, Ernst-Wilhelm Radue, Douglas Goodin, Douglas Jeffery, Kottil W Rammohan, Anthony T Reder, Timothy Vollmer, Mark A Agius, Ludwig Kappos, Tracy Stites, Bingbing Li, Linda Cappiello, Philipp von Rosenstiel, Fred D Lublin

    Résumé Résumé Plan Plan   
• • ·Efficacy of occupational therapy for patients with Parkinson’s disease: a randomised controlled trial

    Page :557-566

    Ingrid H W M Sturkenboom, Maud J L Graff, Jan C M Hendriks, Yvonne Veenhuizen, Marten Munneke, Bastiaan R Bloem, Maria W Nijhuis-van der Sanden, for the OTiP study group †

    Résumé Résumé Plan Plan   
• • ·Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial

    Page :567-574

    Pooja Khatri, Sharon D Yeatts, Mikael Mazighi, Joseph P Broderick, David S Liebeskind, Andrew M Demchuk, Pierre Amarenco, Janice Carrozzella, Judith Spilker, Lydia D Foster, Mayank Goyal, Michael D Hill, Yuko Y Palesch, Edward C Jauch, E Clarke Haley, Achala Vagal, Thomas A Tomsick, for the IMS III Trialists

    Résumé Résumé Plan Plan  
• • ·A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study

    Page :575-586

    Lidia Sabater, Carles Gaig, Ellen Gelpi, Luis Bataller, Jan Lewerenz, Estefanía Torres-Vega, Angeles Contreras, Bruno Giometto, Yaroslau Compta, Cristina Embid, Isabel Vilaseca, Alex Iranzo, Joan Santamaría, Josep Dalmau, Francesc Graus

    Résumé Résumé Plan Plan   
• • ·Painful and painless channelopathies

    Page :587-599

    David L H Bennett, C Geoffrey Woods

    Résumé Résumé Plan Plan   
• • ·Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination

    Page :600-613

    Markku Partinen, Birgitte Rahbek Kornum, Giuseppe Plazzi, Poul Jennum, Ilkka Julkunen, Outi Vaarala

    Résumé Résumé Plan Plan   
• • ·Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria

    Page :614-629

    Bruno Dubois, Howard H Feldman, Claudia Jacova, Harald Hampel, José Luis Molinuevo, Kaj Blennow, Steven T DeKosky, Serge Gauthier, Dennis Selkoe, Randall Bateman, Stefano Cappa, Sebastian Crutch, Sebastiaan Engelborghs, Giovanni B Frisoni, Nick C Fox, Douglas Galasko, Marie-Odile Habert, Gregory A Jicha, Agneta Nordberg, Florence Pasquier, Gil Rabinovici, Philippe Robert, Christopher Rowe, Stephen Salloway, Marie Sarazin, Stéphane Epelbaum, Leonardo C de Souza, Bruno Vellas, Pieter J Visser, Lon Schneider, Yaakov Stern, Philip Scheltens, Jeffrey L Cummings

    Résumé Résumé Plan Plan  
• • ·Long-term cerebral consequences of sepsis

    Page :630-636

    Catherine N Widmann, Michael T Heneka

    Résumé Résumé Plan Plan